History | Inducing labour | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Guidance published

Guidance consultation comments and response (PDF 6.19 MB)

Published:

04 November 2021
Equality impact assessment 4 (PDF 111 KB)

Published:

04 November 2021
Committee member list (PDF 147 KB)

Published:

04 November 2021

Stakeholder list updated

Stakeholder list (PDF 176 KB)

Published:

03 November 2021

Committee meetings

Committee meeting
Minutes 1 (PDF 389 KB)

Published:

02 February 2018
Minutes 2 (PDF 320 KB)

Published:

02 May 2018
Minutes 3 (PDF 315 KB)

Published:

23 July 2018
Minutes 4 (PDF 263 KB)

Published:

05 September 2018
Minutes 5 (PDF 260 KB)

Published:

01 November 2018
Minutes 6 (PDF 206 KB)

Published:

11 December 2018
Minutes 7 (PDF 212 KB)

Published:

29 January 2019
Minutes 8 (PDF 182 KB)

Published:

19 March 2019
Minutes 9 (PDF 194 KB)

Published:

25 September 2019
Minutes 10 (PDF 206 KB)

Published:

25 October 2019
Minutes 11 (PDF 236 KB)

Published:

24 January 2020
Minutes 12 (PDF 182 KB)

Published:

13 July 2020
Minutes 13 (PDF 179 KB)

Published:

15 October 2020
Minutes 14 (MSWord 112 KB)

Published:

18 December 2020
Minutes 15 (PDF 244 KB)

Published:

12 February 2021
Minutes 16 (PDF 167 KB)

Published:

03 March 2021
Minutes 19 (PDF 177 KB)

Published:

05 July 2021
Minutes 20 (PDF 174 KB)

Published:

26 July 2021

Declaration of interests

Register of interests (PDF 535 KB)

Published:

02 August 2021

Draft guidance consultation

Draft guidance consultation
Stakeholder list (PDF 151 KB)

Published:

05 May 2021
Comments form (MSWord 40 KB)

Published:

25 May 2021
Supporting documentation Algorithm (PDF 116 KB)

Published:

25 May 2021
Evidence review A (PDF 1.01 MB)

Published:

25 May 2021
Evidence review B (PDF 11.49 MB)

Published:

25 May 2021
Evidence review C (PDF 2.67 MB)

Published:

25 May 2021
Evidence review D (PDF 1.02 MB)

Published:

25 May 2021
Supporting documentation Glossary (PDF 438 KB)

Published:

25 May 2021
Supporting documentation NGA staff (PDF 162 KB)

Published:

25 May 2021
Supporting documentation Evidence tables (PDF 12.75 MB)

Published:

25 May 2021
Supporting documentation GRADE tables (PDF 2.94 MB)

Published:

25 May 2021
Draft guideline (PDF 581 KB)

Published:

25 May 2021
Comments form (MSWord 40 KB)

Published:

25 May 2021
Supporting documentation Algorithm (PDF 116 KB)

Published:

25 May 2021
Evidence review A (PDF 1.01 MB)

Published:

25 May 2021
Evidence review B (PDF 11.49 MB)

Published:

25 May 2021
Evidence review C (PDF 2.67 MB)

Published:

25 May 2021
Evidence review D (PDF 1.02 MB)

Published:

25 May 2021
Supporting documentation 1 (PDF 438 KB)

Published:

25 May 2021
Supporting documentation 2 (PDF 162 KB)

Published:

25 May 2021
Supporting documentation 3 (PDF 12.75 MB)

Published:

25 May 2021
Supporting documentation 4 (PDF 2.94 MB)

Published:

25 May 2021
Supporting documentation 5 (PDF 472 KB)

Published:

25 May 2021
Equality impact assessment 3 (PDF 113 KB)

Published:

25 May 2021
Committee member list (PDF 147 KB)

Published:

25 May 2021
Draft guideline (PDF 581 KB)

Published:

25 May 2021

Pre-consultation documents released

Economic plan (PDF 117 KB)

Published:

17 March 2021
Review questions (PDF 155 KB)

Published:

17 March 2021
Search strategies (PDF 1.32 MB)

Published:

17 March 2021

Scope published

Final scope (PDF 283 KB)

Published:

18 February 2020